CGMP/Finished Pharmaceuticals/Adulterated
Similar Posts
Empower Clinic Services LLC dba Empower Pharma. Houston, TX. 483 issued 12/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 12/14/2025
Short Title (70 char) Empower Clinic Services LLC dba Empower Pharma. Houston, TX. 483 issued 12/14/2025
FEI Number 3011887629
Firm Name Empower Clinic Services LLC dba Empower Pharma
Record Type 483Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D)
As part of the Accelerating Rare disease Cures (ARC) Program, CDER’s Rare Diseases Team inaugurated the Learning and Education to Advance and Empower Rare Disease Drug Developers (LEADER 3D) initiative. Learn more.Park Avenue Compounding. Saint Louis, MO. 483 issued 09/23/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/23/2025
Short Title (70 char) Park Avenue Compounding. Saint Louis, MO. 483 issued 09/23/2025
FEI Number 1972829
Firm Name Park Avenue Compounding
Record Type 483
State MO
Establishment Type Outsourcing FacilFDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer
On June 12, 2025, the Food and Drug Administration approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).X3 500K GOLD EDITION may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use X3 500K GOLD EDITION, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Krasniy Oktyabr Inc. USA Issues Alert on Eviscerate Dry Salted Vobla “Aral Silver”
KRASNIY OKTYABR INC. USA. of BROOKLYN, NY, is recalling its “ARAL SILVER VOBLA” brand “ARAL”, because the product was found to be uneviscerated.